These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 8362691
1. [Clinical studies of tosufloxacin on chronic bacterial prostatitis]. Ikeuchi T, Kawamura N, Suzuki K, Onodera S, Osada T, Hirano A, Satomi Y, Yoshimura S, Yamamoto Y. Hinyokika Kiyo; 1993 Jul; 39(7):673-8. PubMed ID: 8362691 [Abstract] [Full Text] [Related]
2. [Re-examination of the criteria for clinical evaluation on bacterial prostatitis--analysis of the data of the clinical study of temafloxacin]. Arakawa S, Kamidono S, Hirose T, Kumamoto Y, Suzuki K, Ito Y, Ban Y, Kawada Y, Kumon H, Ohmori H. Hinyokika Kiyo; 1994 May; 40(5):455-66. PubMed ID: 8023771 [Abstract] [Full Text] [Related]
3. [Clinical efficacy of tosufloxacin on the patients with urinary tract infections]. Yoshida K, Kobayashi N, Saitoh H, Negishi T, Yamada T, Watanabe T, Kawakami S, Tari K, Satake I, Ozawa K. Hinyokika Kiyo; 1992 Jan; 38(1):129-34. PubMed ID: 1546562 [Abstract] [Full Text] [Related]
4. [Clinical studies on tosufloxacin (TFLX) in urology]. Fukushima S, Moriyama M, Miyamoto H, Hosaka M, Kubota Y, Kinoshita Y, Noguchi K, Shuin T, Noguchi S, Yoshimura S. Hinyokika Kiyo; 1992 Apr; 38(4):501-6. PubMed ID: 1529827 [Abstract] [Full Text] [Related]
5. [Therapeutic studies on chronic prostatitis--use of AT-2266--Sapporo Clinical Research Group for STD]. Kumamoto Y, Sakai S, Tamate H, Gohro T, Inoke T, Tabata S, Tanda H, Kato S, Saka T, Henmi I. Hinyokika Kiyo; 1986 Aug; 32(8):1213-23. PubMed ID: 3466522 [Abstract] [Full Text] [Related]
11. [Clinical and bacteriological study of sparfloxacin on bacterial prostatitis]. Suzuki K, Horiba M, Naide Y, Shinoda M, Hibi H. Hinyokika Kiyo; 1992 Jan; 38(1):121-8. PubMed ID: 1312292 [Abstract] [Full Text] [Related]
12. Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis. Naber KG, Roscher K, Botto H, Schaefer V. Int J Antimicrob Agents; 2008 Aug; 32(2):145-53. PubMed ID: 18571904 [Abstract] [Full Text] [Related]
13. Assessment of the UTI criteria for bacterial prostatitis in Japan. Arakawa S, Kamidono S. Infection; 1992 Aug; 20 Suppl 3():S232-4. PubMed ID: 1337062 [Abstract] [Full Text] [Related]
14. [The therapeutic effect of norfloxacin on chronic prostatitis]. Morikawa M, Tokunaka S, Yachiku S, Yamauchi K, Wakabayashi A, Inagaki N, Nishihara M, Yamaguchi S. Hinyokika Kiyo; 1990 Oct; 36(10):1253-7. PubMed ID: 2264550 [Abstract] [Full Text] [Related]
15. [Laboratory and clinical study of ofloxacin in the treatment of bacterial prostatitis]. Suzuki K, Tamai H, Naide Y, Ando K, Moriguchi R. Hinyokika Kiyo; 1984 Oct; 30(10):1505-18. PubMed ID: 6596877 [Abstract] [Full Text] [Related]
16. [Clinical efficacy of T-3262, a new quinolone compound, on urinary tract infection in 1988]. Suzuki K, Nagata Y. Hinyokika Kiyo; 1989 Apr; 35(4):717-26. PubMed ID: 2735274 [Abstract] [Full Text] [Related]
17. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context. Ball P, Mandell L, Patou G, Dankner W, Tillotson G. Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718 [Abstract] [Full Text] [Related]
18. [Preventive chemotherapy after transurethral prostatectomy: a randomized study]. Yoshida O, Arai Y, Takeuchi H, Fukuyama T, Hida S, Ikeda T, Okabe T, Kuo SY, Kounami T, Nakagawa T. Hinyokika Kiyo; 1993 May; 39(5):491-6. PubMed ID: 7686715 [Abstract] [Full Text] [Related]